Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Firazyr advisory committee canceled

Executive Summary

Jerini's hereditary angiodema treatment Firazyr (icatibant) will not undergo a review by FDA's Pulmonary-Allergy Drugs Advisory Committee, the firm says Jan. 8. The panel was scheduled to meet Feb. 20 to discuss the orphan drug candidate, which has an April 26 user fee date under priority review...

You may also be interested in...



To Meet Or Not To Meet? That Is CDER’s Question As Cmte. Cancellations Rise

Clinical development and regulatory review are already full of uncertainties, but this year FDA introduced a new twist - canceling and postponing advisory committee meetings. Almost half of the scheduled meetings have not taken place, which may or may not be a bad sign for industry

ANI Pharmaceuticals Completes $210m Novitium Acquisition

ANI Pharmaceuticals has completed its acquisition of niche generics specialist Novitium Pharma, securing access to a pipeline of generics and 505(b)(2) candidates that has expanded further since the deal was announced earlier in the year.

Consumer Health Industry Ideally Placed To Lead And Benefit From Climate Fight

Consumer healthcare firms are perfectly placed to lead the charge in fighting climate change while benefitting from the transition to a greener, healthier world. However, taking advantage of the green opportunity means putting environmental, social and governance (ESG) at the center of how OTC companies measure and reward success and treating the health of people and planet as a single, related issue, argues Bayer Consumer Health's sustainability guru Daniella Foster. 

UsernamePublicRestriction

Register

PS049180

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel